In the BioHarmony Drug Report Database

"Preview" Icon

Cobicistat

Tybost (cobicistat) is a small molecule pharmaceutical. Cobicistat was first approved as Tybost on 2013-09-19. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Stribild’s patents are valid until 2032-10-06 (FDA).

 

Trade Name

 

Tybost
 

Common Name

 

cobicistat
 

ChEMBL ID

 

CHEMBL2095208
 

Indication

 

hiv infections
 

Drug Class

 

Enzyme inhibitors

Image (chem structure or protein)

Cobicistat structure rendering